Abstract:188 Objectives: Although various types of imaging agents have been developed for photoacoustic (PA) imaging, relatively few imaging agents exhibit high selectivity/sensitivity to the tumor microenvironment for on-demand PA imaging and therapy. Meantime, a common concern about nanoparticles for PA imaging is the nonspecific uptake by mononuclear phagocyte systems (e.g., liver/spleen) and low accumulation in tumors due to the poor enhanced permeability and retention (EPR) effect. Our goal is to develop an intelligent theranostic agent, which can remain as small molecules during circulation in the bloodstream, self-assemble into larger nanostructures in the tumor, and then be activated by the tumor microenvironment for PA imaging-guided tumor therapy. Methods: Herein, we reported molybdenum-based polyoxometalate (POM) clusters with the highest oxidation state of Mo(VI) (denoted as Ox-POM) as novel agents for redox-activated PA imaging-guided photothermal therapy (PTT). Capable of escaping from recognition and capture by the liver and spleen, these renal clearable clusters with ultra-small size can accumulate in the tumor, self-assemble into larger nanoclusters at low pH, and are reduced to near-infrared (NIR) absorptive agents in the tumor microenvironment. Systematic in vitro and in vivo experiments were performed to evaluate their bioresponsive and theranostic capability. Results: These Ox-POMs were highly uniform with their hydrated size increasing from 1.9 nm (pH = 7.4) to 29.3 nm (pH = 6.5) and to ∼0.43 μm at pH 5.0. The clusters showed no NIR absorption in their original chemical form but exhibited strong NIR absorption because Mo(VI) is reduced to Mo(V) when incubated with glutathione (GSH), exhibiting high-performance PA imaging and photothermal conversion in vitro. The PET imaging of 89Zr-Ox-POM results showed these clusters could escape from recognition by the liver and spleen and were mainly excreted through the kidneys, which is highly desirable for reducing the potential toxic effects. Studies in 4T1 tumor-bearing mice indicated that these clusters could be employed for bioresponsive PA imaging-guided tumor ablation in vivo. The PA signal was detected in the tumors as early as 1 h p.i., demonstrating the strong redox-activated effect of Ox-POM by the tumor redox status. The temperature of the tumor rapidly increased to above 40 °C in 30 s and reached 52 °C in 5 min under laser irradiation, and the tumor growth was eliminated without subsequent recurrence for a prolonged period of up to 2 months, whereas the control groups demonstrated rapid tumor growth. CONCLUSION: In summary, we present here the redox-activated Ox-POM clusters for tumor microenvironment-responsive PA imaging-guided tumor ablation. Importantly, these bioresponsive clusters with long in vivo circulation half-life can be passively accumulated in the tumor, self-assemble into larger nanosizes under the tumor’s acidic environment, and be reduced to NIR absorptive agents for efficient PA imaging-guided PTT of cancer. As a proof-of-concept, this finding is expected to establish a new class of redox-activated probes based on clusters, bridging the conventional concepts of “molecule” and “nano” in the bioimaging field.

Polyoxometalates Nanoparticles Improve Anti-Tumor Activity by Maximal Cellular Uptake

Enhanced antitumor activity of polyoxometalates loaded solid lipid nanoparticles

Tris‐functionalized polyoxotungstovanadate‐mediated antitumor efficacy involves multiple cell death pathways

Combinatorial discovery of Mo-based polyoxometalate clusters for tumor photothermal therapy and normal cell protection

Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.

Lindqvist-type Polyoxometalates Act as Anti-breast Cancer Drugs via Mitophagy-induced Apoptosis

Polyoxometalate Modified by Zeolite Imidazole Framework for the Ph-Responsive Electrodynamic/Chemodynamic Therapy

Antitumor Effects of a Sb-rich Polyoxometalate on Non-Small-Cell Lung Cancer by Inducing Ferroptosis and Apoptosis

Photothermal and enhanced chemodynamic reinforced anti-tumor therapy based on PDA@POM nanocomposites

A Nanomedicine Based on Stoichiometric Coordination of Camptothecin and Organoplatinum (II) for Synergistic Antitumor Therapy.

Degradable Organically-Derivatized Polyoxometalate with Enhanced Activity Against Glioblastoma Cell Line.

Hetero-bimetallic Transition Metal-Substituted Krebs-type Polyoxometalate with N-chelating Ligand As Anticancer Agents

Redox-Activated Photoacoustic Imaging-Guided Photothermal Therapy with Bioresponsive Polyoxometalate Cluster

Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy

Biomimetic layered molybdenum oxide nanosheets with excellent photothermal property combined with chemotherapy for enhancing anti-tumor immunity

Progress in the Synthesis of Heteropolyoxometalate Clusters Andtheir Applications in Biological Treatment

Controllable Assembly of Mo VI 36 -Based Polyoxometalate Porous Frameworks with Silver Ions and Lung Cancer Cell-Specific Cytotoxicity

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)

Functionalized Periodic Mesoporous Organosilica Nanoparticles for Combinational Chemo-Photothermal Antitumor Therapy

Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors